754 related articles for article (PubMed ID: 8636774)
1. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
[TBL] [Abstract][Full Text] [Related]
2. Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant.
Corvò R; Paoli G; Barra S; Bacigalupo A; Van Lint MT; Franzone P; Frassoni F; Scarpati D; Bacigalupo A; Vitale V
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):497-503. PubMed ID: 10078628
[TBL] [Abstract][Full Text] [Related]
3. Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.
Giralt SA; LeMaistre CF; Vriesendorp HM; Andersson BS; Dimopoulos M; Gajewski J; Van Besien K; Mehra R; Przepiorka D; Khouri I
J Clin Oncol; 1994 Sep; 12(9):1923-30. PubMed ID: 8083714
[TBL] [Abstract][Full Text] [Related]
4. Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients.
Belkacémi Y; Pène F; Touboul E; Rio B; Leblond V; Gorin NC; Laugier A; Gemici C; Housset M; Ozsahin M
Strahlenther Onkol; 1998 Feb; 174(2):92-104. PubMed ID: 9487372
[TBL] [Abstract][Full Text] [Related]
5. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
6. Total body irradiation before allogeneic bone marrow transplantation: is more dose better?
Bieri S; Helg C; Chapuis B; Miralbell R
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1071-7. PubMed ID: 11240249
[TBL] [Abstract][Full Text] [Related]
7. Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings.
Zecca M; Pession A; Messina C; Bonetti F; Favre C; Prete A; Cesaro S; Porta F; Mazzarino I; Giorgiani G; Rondelli R; Locatelli F
J Clin Oncol; 1999 Jun; 17(6):1838-46. PubMed ID: 10561223
[TBL] [Abstract][Full Text] [Related]
8. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
9. Cataract-free interval and severity of cataract after total body irradiation and bone marrow transplantation: influence of treatment parameters.
van Kempen-Harteveld ML; Struikmans H; Kal HB; van der Tweel I; Mourits MP; Verdonck LF; Schipper J; Battermann JJ
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):807-15. PubMed ID: 11020578
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide.
Hartsell WF; Czyzewski EA; Ghalie R; Kaizer H
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):69-73. PubMed ID: 7536723
[TBL] [Abstract][Full Text] [Related]
11. Factors Influencing Pulmonary Toxicity in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in the Setting of Total Body Irradiation-Based Myeloablative Conditioning.
Abugideiri M; Nanda RH; Butker C; Zhang C; Kim S; Chiang KY; Butker E; Khan MK; Haight AE; Chen Z; Esiashvili N
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):349-59. PubMed ID: 26853343
[TBL] [Abstract][Full Text] [Related]
12. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation.
Della Volpe A; Ferreri AJ; Annaloro C; Mangili P; Rosso A; Calandrino R; Villa E; Lambertenghi-Deliliers G; Fiorino C
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):483-8. PubMed ID: 11872296
[TBL] [Abstract][Full Text] [Related]
13. The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation.
Bacigalupo A; Vitale V; Corvò R; Barra S; Lamparelli T; Gualandi F; Mordini N; Berisso G; Bregante S; Raiola AM; Van Lint MT; Frassoni F
Br J Haematol; 2000 Jan; 108(1):99-104. PubMed ID: 10651732
[TBL] [Abstract][Full Text] [Related]
14. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
[TBL] [Abstract][Full Text] [Related]
15. Renal toxicity in children undergoing total body irradiation for bone marrow transplant.
Esiashvili N; Chiang KY; Hasselle MD; Bryant C; Riffenburgh RH; Paulino AC
Radiother Oncol; 2009 Feb; 90(2):242-6. PubMed ID: 18973960
[TBL] [Abstract][Full Text] [Related]
16. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
[TBL] [Abstract][Full Text] [Related]
18. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment.
Miralbell R; Sancho G; Bieri S; Carrió I; Helg C; Brunet S; Martin PY; Sureda A; Gomez De Segura G; Chapuis B; Estorch M; Ozsahin M; Keller A
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):809-16. PubMed ID: 14967438
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation.
Lawton CA; Cohen EP; Murray KJ; Derus SW; Casper JT; Drobyski WR; Horowitz MM; Moulder JE
Bone Marrow Transplant; 1997 Dec; 20(12):1069-74. PubMed ID: 9466280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
